Turn Up the Heat Tickets Now Available
Turn Up the Heat Tickets Now Available
Tickets are now available for the 2017 Turn Up the Heat! Gala in Washington DC. Turn Up the Heat features food from the top female chefs in DC and the … Continued
News
Kolker Fellowship Deadline Approaching
Kolker Fellowship Deadline Approaching
The Kolker Fellowship commemorates the legacy of pioneering health policy advocate Ann Kolker. At the time Ann was diagnosed with ovarian cancer in 1996, she was already a political powerhouse, having … Continued
FDA Approves Avastin for Platinum-Sensitive Recurrent Ovari...
FDA Approves Avastin for Platinum-Sensitive Recurrent Ovarian Cancer
(Dec. 9, 2016) This week Genentech announced that the US Food and Drug Administration has expanded approval for bevacizumab (Avastin) to include patients with platinum-sensitive, recurrent disease, either in combination … Continued
Managing Recurrence: What You Need to Know (Webinar Available)
Managing Recurrence: What You Need to Know (Webinar Available)
Recurrence is in the back of every ovarian cancer survivor’s mind. In this presentation, originally broadcast on November 28, 2016, Dr. Sarah Adams provided an overview of strategies for managing … Continued
OCRFA Welcomes New Scientific Advisory Committee Members
OCRFA Welcomes New Scientific Advisory Committee Members
OCRFA recently welcomed four new members to the Scientific Advisory Committee (SAC), our world-class group of leaders in the ovarian cancer field who review and approve all OCRFA research grants. … Continued
OCRFA Funded Research Identifies Protein Group Responsible ...
OCRFA Funded Research Identifies Protein Group Responsible For Senescence’s Negative Side Effects
(Nov. 3, 2016) Senescence is the state when normal, healthy cells no longer have the ability to divide, which can occur during chemotherapy or when cancer genes within that cell … Continued
OCRFA Funded Study Explores New Role of Estrogen in Anti-Tu...
OCRFA Funded Study Explores New Role of Estrogen in Anti-Tumor Immunity
(October 31, 2016) Estrogen signaling is a known factor in how certain estrogen receptive (ER positive) tumors grow in breast and ovarian cancers. That signaling, which can promote malignant tumor … Continued
OCRFA Launches New Website
OCRFA Launches New Website
We’re excited to announce that OCRFA’s new and refreshed website is live. The new site is reflective of the merger of Ovarian Cancer Research Fund and the Ovarian Cancer National … Continued
OCRFA applauds FDA’s statement on ovarian cancer screening ...
OCRFA applauds FDA’s statement on ovarian cancer screening test
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated. The FDA states, “despite extensive … Continued
Risk-reducing Oophorectomy is Risky, Study Shows
Risk-reducing Oophorectomy is Risky, Study Shows
A Mayo Clinic research team has found evidence suggesting that premenopausal women who are not at high risk of ovarian cancer should not have their ovaries removed for the purpose … Continued
Niraparib Significantly Improves Outcome of Ovarian Cancer ...
Niraparib Significantly Improves Outcome of Ovarian Cancer Patients
(October 11, 2016) According to research published this month in the New England Journal of Medicine, the PARP inhibitor niraparib improves progression free survival in recurrent, platinum-sensitive women both with … Continued
#30DaysofTeal: Day 30
#30DaysofTeal: Day 30
Our #30DaysofTeal campaign spotlighted education and awareness facts about ovarian cancer. You, this amazing and strong community helped us educate 2.5 MILLION people about ovarian cancer throughout September. But awareness … Continued